Data monitoring committees for clinical trials and the role of the statistician

Interview with David Kerr

Join us while we discuss these questions with David and learn more about the following points:

• How did David get to this position as a biostatistician at a CRO?
• How is it made sure that information from the DMC stays within the DMC?
• What is David's most challenging and most exciting experience he had while working in a DMC setting?
• When working on open-label trials, it is sometimes requested to “artificially” blind the date but have a DMC review the unblinded data. Has he come across these settings as well, and what’s the challenge he sees here?

References:

https://www.linkedin.com/in/dmcdavid/

https://www.cytel.com/blog/0-key-qualifications-for-independent-statisticians-reporting-to-the-dmc

Listen to this episode and share it with your friends and colleagues!